Skip to content
Hesperos Inc.
Hesperos Inc.
  • Technology
  • Services
  • About Us
  • Publications
  • News
  • Contact Us
    • Get a Quote
    • Careers
Hesperos Inc.
  • Technology
  • Services
  • About Us
  • Publications
  • News
  • Contact Us
    • Get a Quote
    • Careers

News

Recent News About Hesperos and Human-on-a-Chip Technology

Dr. Shuler to be Keynote Speaker at Lab-On-Chip World Congress

By Hesperos | September 3, 2015 | 0 Comments
shuler

San Diego, CA:  Sept 28 – 30, 2015 Focusing specifically on his work with Body-On-A-Chip technologies, Dr. Shuler will be a keynote speaker at the conference in San Diego later this month.   Click here to learn … Read More

  • « Previous
  • 1
  • …
  • 5
  • 6
  • 7

Categories

  • Latest News
  • Press Releases

Archives

  • May 2022
  • April 2022
  • November 2021
  • August 2021
  • June 2021
  • May 2021
  • April 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • May 2020
  • November 2019
  • September 2019
  • July 2019
  • June 2019
  • March 2019
  • January 2019
  • October 2018
  • September 2018
  • August 2018
  • April 2018
  • March 2018
  • January 2018
  • November 2017
  • October 2017
  • August 2017
  • January 2017
  • September 2016
  • November 2015
  • September 2015

Recent Posts

  • Dr. Kronauge appointed as CEO
  • Hesperos Shows Potential for In Vitro Approach to Replace Conventional Animal Efficacy Studies for Rare Neuromuscular Disorders
  • Hesperos Validates Utility of Human-on-a-ChipĀ® Approach to Model Rare Autoimmune Disease, Myasthenia Gravis
  • Hesperos & Tabula Rasa Awarded $1.9M NIH Grant to investigate preventable Drug-induced Alzheimer’s Disease
  • Nature Scientific Reports Study Validates Utility of Human-on-a-Chip to Model NAFLD

Contact Information

Hesperos, Inc.
12501 Research Pkwy, Suite 100
Orlando, FL 32826

Phone: (407) 900-5915

Follow Us

Important Links

  • Home2
  • Organ on a Chip Company
  • Human on a Chip Services
  • Contact Us
  • Privacy Policy

Latest News

  • Dr. Kronauge appointed as CEO
  • Hesperos Shows Potential for In Vitro Approach to Replace Conventional Animal Efficacy Studies for Rare Neuromuscular Disorders
© 2022 Hesperos, Inc.
  • Technology
  • Services
  • About Us
  • Publications
  • News
  • Contact Us
    • Get a Quote
    • Careers